Insmed Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€20.00
Target price
04.08.24
€37.17
Performance (%)
237.50%
End price
05.08.24
€67.50
Summary
This prediction ended on 05.08.24 with a price of €67.50. With a performance of 237.50% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Insmed Inc. | 1.985% | 1.985% | 0.901% | 462.814% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
Comments by Morgan_Stanley for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $41.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten